Related Experiment Video

Updated: Jul 19, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Neurocognitive outcomes in pediatric HIV

Elizabeth J Willen1

  • 1Mailman Center for Child Development, Department of Pediatrics, University of Miami Leonard M. Miller School of Medicine, Miami, Florida 33101, USA. ewillen@med.miami.edu

Mental Retardation and Developmental Disabilities Research Reviews
|October 25, 2006
PubMed

Insights

Vertically infected children with HIV can experience cognitive impairment due to the virus impacting brain development. Factors influencing these neurocognitive outcomes are reviewed, considering different treatment eras.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Neurodevelopmental Disorders

Background:

  • Human Immunodeficiency Virus (HIV) infection in children can affect cognitive function.
  • The developing brain is vulnerable to direct and indirect impacts of HIV.
  • Neurocognitive outcomes vary significantly among vertically infected children.

Purpose of the Study:

  • To review the literature on neurocognitive outcomes in vertically HIV-infected children.
  • To examine factors influencing neurodevelopment in this population.
  • To discuss interventions and future research directions.

Main Methods:

  • Literature review of studies on neurocognitive outcomes in vertically HIV-infected infants, children, and youth.
  • Analysis of factors impacting neurocognition within a developmental framework.
  • Comparison of findings from pre- and post-combined therapy eras.

Main Results:

  • HIV can cause a spectrum of cognitive impairments, from mild to severe disability.
  • Multiple factors influence the individual neurocognitive impact of HIV.
  • Prevalence of cognitive issues persists in resource-limited settings despite advances in therapy.

Conclusions:

  • Understanding the factors influencing neurocognitive outcomes is crucial for managing vertically HIV-infected children.
  • Continued research and targeted interventions are needed to mitigate cognitive deficits.
  • The long-term impact of HIV on neurodevelopment requires ongoing attention, particularly in global health contexts.

More Related Videos

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice07:23

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

Published on: December 20, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...